Key result
Higher HbA1c levels are linked to an increased risk of incident CHD in nondiabetic adults.
Case-Control
Answers are grounded in this paper and cite their sources.
BACKGROUND: Hemoglobin A1c (HbA1c), a time-integrated marker of glycemic control, predicts risk of coronary heart disease (CHD) among diabetics. Few studies have examined HbA1c and risk of CHD among women and men without clinically elevated levels or previously diagnosed diabetes. METHODS AND RESULTS: We conducted parallel nested case-control studies among women (Nurses' Health Study) and men (Health Professionals Follow-up Study). During 14 and 10 years of follow-up, 468 women and 454 men developed incident nonfatal myocardial infarction (MI) and fatal CHD. Controls were matched 2:1 based on age, smoking, and date of blood draw. For these analyses, participants with a history of diabetes or HbA1c levels ≥6.5% at baseline were excluded. Compared with HbA1c of 5.0% to <5.5%, those with an HbA1c of 6.0% to <6.5% had a multivariable-adjusted relative risk (RR) of CHD of 1.90 (95% CI 1.11 to 3.25) in women and 1.81 (95% CI 1.09 to 3.03) in men. The pooled RR of CHD was 1.29 (95% CI 1.11 to 1.50) for every 0.5%-increment increase in HbA1c levels and 1.67 (95% CI 1.23 to 2.25) for every 1%-increment increase, with the risk plateauing around 5.0%. Furthermore, participants with HbA1c levels between 6.0% and <6.5% and C-reactive protein levels >3.0 mg/L had a 2.5-fold higher risk of CHD compared with participants in the lowest categories of both biomarkers. CONCLUSIONS: Our findings suggest that HbA1c is associated with CHD risk among apparently healthy, nondiabetic women and men and may be an important early clinical marker of disease risk.
No takes yet. Share an insight, caveat, or question.
Pai et al. (2013) conducted a case-control in Incident coronary heart disease in nondiabetic men and women. Elevated baseline Hemoglobin A1c (HbA1c) vs. HbA1c of 5.0% to <5.5% (or per 1% / 0.5% increment) was evaluated on Incident nonfatal myocardial infarction and fatal coronary heart disease (RR 1.67, 95% CI 1.23-2.25). Each 1%-increment increase in HbA1c was associated with an increased risk of incident CHD among nondiabetic adults.
Synapse has enriched 10 related papers. Consider them for comparative context: